Back to News
Market Impact: 0.18

Should You Buy the $1.75 Trillion SpaceX IPO? Here Is What History Says

PLTRSNOWFIGNFLXNVDAINTCTSLA
IPOs & SPACsTechnology & InnovationCompany FundamentalsPrivate Markets & VentureInvestor Sentiment & Positioning

SpaceX is being discussed as a potential $2 trillion IPO, but the article argues investors should wait rather than buy at launch. It cites recent tech listings like Palantir, Snowflake, and Figma to show that opening-day pops often fade and can leave buyers underwater for extended periods. The piece is a cautionary valuation and timing commentary, not a new fundamental update on SpaceX.

Analysis

The market is likely to confuse “largest IPO ever” with “best post-IPO entry,” and that usually creates a dangerous first-week liquidity trap. The bigger second-order issue is not just valuation compression, but the supply overhang that arrives when early holders, employees, and crossover investors finally get a chance to monetize; in capital-intensive, narrative-heavy names, that supply often caps upside for months even if the business continues to compound. SpaceX’s real risk/reward asymmetry is that the public market will force a much higher bar for capital efficiency than private investors have tolerated. If growth slows even modestly, the denominator effect at a near-trillion-plus starting valuation can erase years of operating progress; in that setup, a 15-20% post-IPO drawdown would be more a function of multiple normalization than fundamental deterioration. The market will likely reward evidence of recurring, high-margin cash flow from Starlink more than launch cadence, because software-like economics are what can support a premium multiple over time. The overlooked winner is likely the broader private-market ecosystem: secondary liquidity providers, late-stage crossover funds, and adjacent satellite/networking suppliers that can benefit from a re-rating cycle without taking direct IPO execution risk. By contrast, public comps with stretched narratives and no clear earnings acceleration path — especially the names already trading as “AI-plus-vision” stories — could see sentiment spillover as investors rotate toward cleaner balance sheets and more legible cash conversion. The contrarian view is that waiting may be optimal not because SpaceX is bad, but because the first tradable price is almost certain to include a scarcity premium. A better entry may come after the lock-up calendar, when incremental supply meets the market’s need for quarterly proof rather than visionary slides; that window is usually measured in 3-9 months, not days. If the company delivers even one clean reporting cycle with improving operating leverage, the stock can reset higher from a more attractive base.